Skip to content
healthcare.dev

Uretron D/S

NDC 12539-144, Methenamine, Sodium Phosphate Monobasic, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate, tablet, from DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals.

Product NDC
12539-144
Status
Listed
Labeler
DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/12539-144 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE40.8 mg/1
  • PHENYL SALICYLATE36.2 mg/1
  • HYOSCYAMINE SULFATE.12 mg/1
  • METHYLENE BLUE10.8 mg/1
  • METHENAMINE81.6 mg/1

Pharmacologic classes

Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Oxidation-Reduction Activity [MoA]; Oxidation-Reduction Agent [EPC]

Package NDCNDC-11Package
12539-144-0112539014401100 TABLET in 1 BOTTLE (12539-144-01)

Linked data

RxNorm, label and prices

Use it

Look up 12539-144 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/12539-144 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 12539-144. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.